Literature DB >> 19243896

CD24 expression has a prognostic impact in breast carcinoma.

Pauline Athanassiadou1, Dimitra Grapsa, Maria Gonidi, Anna-Maria Athanassiadou, Angelos Tsipis, Efstratios Patsouris.   

Abstract

We investigated the prognostic significance of BAG-1 and CD24 in invasive breast carcinomas. Seventy cases of invasive breast carcinoma were studied immunocytochemically for the expression of BAG-1 and CD24. The results were correlated with several prognostic parameters, including 5-year survival. Univariate analysis showed a significant correlation of BAG-1 and CD24 overall positive staining with several adverse prognostic parameters, such as increased stage (p<0.0001), tumor grade 3 (p=0.016 and p=0.02, respectively), positive lymph nodes (p<0.0001), and increased tumor size (p<0.0001). Similar results were found for BAG-1 nuclear staining, as well as for positive cytoplasmic CD24 expression. Both of our markers studied had a significant, negative effect on survival. Multivariate analysis further revealed an independent prognostic impact for CD24 overall staining. The results of our study showed that overall cytoplasmic and especially nuclear BAG-1 expression, as well as overall and cytoplasmic CD24 expression, correlates with adverse prognostic parameters. An independent prognostic value for overall CD24 staining was also demonstrated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19243896     DOI: 10.1016/j.prp.2009.01.008

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  19 in total

1.  CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance.

Authors:  Sibel Bektas; Burak Bahadir; Bulent Hamdi Ucan; Sukru Oguz Ozdamar
Journal:  Pathol Oncol Res       Date:  2010-02-23       Impact factor: 3.201

Review 2.  CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.

Authors:  Yixin Tan; Ming Zhao; Bo Xiang; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

3.  CD24 genetic variants contribute to overall survival in patients with gastric cancer.

Authors:  Zhi-Fang Jia; Li-Zhong Wang; Xue-Yuan Cao; Chuan Wang; Dong-Hui Cao; Xing Wu; Li-Li You; Mei-Shan Jin; Yin-Ping Wang; Bao-Sen Zhou; Jing Jiang
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

4.  CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization.

Authors:  Jonathan B Overdevest; Shibu Thomas; Glen Kristiansen; Donna E Hansel; Steven C Smith; Dan Theodorescu
Journal:  Cancer Res       Date:  2011-04-11       Impact factor: 12.701

5.  CD44/CD24 as potential prognostic markers in node-positive invasive ductal breast cancer patients treated with adjuvant chemotherapy.

Authors:  Agnieszka Adamczyk; Joanna A Niemiec; Aleksandra Ambicka; Anna Mucha-Małecka; Jerzy Mituś; Janusz Ryś
Journal:  J Mol Histol       Date:  2013-07-09       Impact factor: 2.611

6.  The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients.

Authors:  Alexandra Giatromanolaki; Efthimios Sivridis; Aliki Fiska; Michael I Koukourakis
Journal:  Med Oncol       Date:  2010-04-20       Impact factor: 3.064

Review 7.  CD24: from A to Z.

Authors:  Xianfeng Fang; Pan Zheng; Jie Tang; Yang Liu
Journal:  Cell Mol Immunol       Date:  2010-02-15       Impact factor: 11.530

8.  Clinicopathological analysis of CD44 and CD24 expression in invasive breast cancer.

Authors:  Min Hye Jang; Hyun Jong Kang; Ki Seok Jang; Seung Sam Paik; Wan Seop Kim
Journal:  Oncol Lett       Date:  2016-08-10       Impact factor: 2.967

9.  Epithelial Ovarian Cancer and Cancer Stem Cells.

Authors:  Amr A Soliman; Alaa A Elzarkaa; Eduard Malik
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Determination of 35 cell surface antigen levels in malignant pleural effusions identifies CD24 as a marker of disseminated tumor cells.

Authors:  Xiaosai Yao; Myriam Labelle; Carla R Lamb; John M Dugan; Christina A Williamson; Donna R Spencer; Kimberly R Christ; Ryan O Keating; W David Lee; Glenn A Paradis; Shahinoor Begum; Richard O Hynes; K Dane Wittrup
Journal:  Int J Cancer       Date:  2013-07-13       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.